# To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)

> **NCT06177249** · PHASE3 · COMPLETED · sponsor: **Hualan Biological Bacterin Co. Ltd.** · enrollment: 1956 (actual)

## Conditions studied

- Rabies Human

## Interventions

- **BIOLOGICAL:** Control vaccine
- **BIOLOGICAL:** Experimental vaccine

## Key facts

- **NCT ID:** NCT06177249
- **Lead sponsor:** Hualan Biological Bacterin Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-15
- **Primary completion:** 2015-12-16
- **Final completion:** 2016-05-01
- **Target enrollment:** 1956 (ACTUAL)
- **Last updated:** 2023-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06177249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06177249, "To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06177249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*